Tandem Investment Advisors Inc. cut its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 17.9% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 9,772 shares of the medical equipment provider's stock after selling 2,133 shares during the period. Tandem Investment Advisors Inc.'s holdings in Intuitive Surgical were worth $4,801,000 as of its most recent SEC filing.
Several other hedge funds have also recently bought and sold shares of ISRG. Hazlett Burt & Watson Inc. raised its holdings in Intuitive Surgical by 5.8% during the 3rd quarter. Hazlett Burt & Watson Inc. now owns 362 shares of the medical equipment provider's stock worth $177,000 after buying an additional 20 shares during the period. Ullmann Wealth Partners Group LLC grew its stake in Intuitive Surgical by 1.6% in the third quarter. Ullmann Wealth Partners Group LLC now owns 1,329 shares of the medical equipment provider's stock valued at $653,000 after purchasing an additional 21 shares in the last quarter. One Wealth Management Investment & Advisory Services LLC grew its stake in shares of Intuitive Surgical by 3.4% in the 2nd quarter. One Wealth Management Investment & Advisory Services LLC now owns 697 shares of the medical equipment provider's stock valued at $310,000 after buying an additional 23 shares in the last quarter. Falcon Wealth Planning raised its holdings in Intuitive Surgical by 0.4% during the third quarter. Falcon Wealth Planning now owns 5,693 shares of the medical equipment provider's stock valued at $2,797,000 after buying an additional 23 shares in the last quarter. Finally, Daymark Wealth Partners LLC lifted its stake in shares of Intuitive Surgical by 0.3% in the third quarter. Daymark Wealth Partners LLC now owns 7,027 shares of the medical equipment provider's stock worth $3,452,000 after buying an additional 24 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors.
ISRG opened at $524.28 on Friday. Intuitive Surgical, Inc. has a 12-month low of $269.49 and a 12-month high of $525.00. The stock has a 50-day moving average price of $492.30 and a 200-day moving average price of $450.05. The stock has a market capitalization of $186.74 billion, a P/E ratio of 84.29, a PEG ratio of 4.99 and a beta of 1.39.
In related news, SVP Henry L. Charlton sold 40,243 shares of Intuitive Surgical stock in a transaction that occurred on Friday, August 23rd. The stock was sold at an average price of $486.84, for a total transaction of $19,591,902.12. Following the sale, the senior vice president now directly owns 3,001 shares in the company, valued at $1,461,006.84. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. In related news, SVP Henry L. Charlton sold 40,243 shares of the stock in a transaction dated Friday, August 23rd. The shares were sold at an average price of $486.84, for a total value of $19,591,902.12. Following the completion of the transaction, the senior vice president now directly owns 3,001 shares in the company, valued at $1,461,006.84. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Gary S. Guthart sold 18,151 shares of the business's stock in a transaction dated Wednesday, October 30th. The stock was sold at an average price of $511.63, for a total transaction of $9,286,596.13. Following the sale, the chief executive officer now directly owns 24,219 shares in the company, valued at $12,391,166.97. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 68,246 shares of company stock valued at $33,839,308. 0.90% of the stock is currently owned by corporate insiders.
A number of analysts have weighed in on ISRG shares. The Goldman Sachs Group set a $604.00 price target on shares of Intuitive Surgical in a report on Friday, October 18th. Royal Bank of Canada boosted their target price on Intuitive Surgical from $525.00 to $555.00 and gave the stock an "outperform" rating in a report on Friday, October 18th. BTIG Research set a $535.00 target price on Intuitive Surgical in a research note on Friday, October 18th. Mizuho increased their price target on shares of Intuitive Surgical from $440.00 to $500.00 in a research report on Thursday, October 17th. Finally, Wells Fargo & Company increased their price objective on shares of Intuitive Surgical from $466.00 to $549.00 and gave the stock an "overweight" rating in a research report on Friday, October 18th. One analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have given a buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $513.74.
Check Out Our Latest Research Report on ISRG
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Before you consider Intuitive Surgical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.
While Intuitive Surgical currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.